PFSA
Profusa, Inc. Common StockNASDAQHealthcare$0.76+30.98%ClosedMarket Cap: $422,048
As of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
-0.01
P/S
0.00
EV/EBITDA
-0.60
DCF Value
$-120.21
FCF Yield
-2753.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
89.6%
ROA
-957.4%
ROIC
194.1%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $0.00 | $-22.2M | $-52.50 |
| Q2 2025 | $0.00 | $-8.2M | $-18.75 |
| Q1 2025 | $0.00 | $-2.7M | $-6.21 |
| Q4 2024 | $0.00 | $-7.6M | $-96.75 |
Trading Activity
Insider Trades
View AllKnechtel Fred S.officer: Chief Financial Officer
SellMon Feb 02
Knechtel Fred S.officer: Chief Financial Officer
SellMon Feb 02
NorthView Sponsor I, LLC10 percent owner
SellMon Feb 02
NorthView Sponsor I, LLC10 percent owner
SellMon Feb 02
O'Rourke Peterdirector
SellFri Jan 30
Company Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NASDAQ
Beta
0.26
A digital-health company developing tissue-integrating biosensors (e.g. the Lumee™ Oxygen Platform) to continuously monitor body chemistry and provide AI-powered health insights, targeting chronic conditions such as diabetes and critical limb ischemia